Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the radiotherapydadjuvant versus early salvage (RAVES) trial: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)538
    Number of pages1
    JournalJournal of Urology
    Issue number2
    StatePublished - Feb 1 2015

    ASJC Scopus subject areas

    • Urology

    Cite this